Gosebruch Henry O
CIK: 0001659625•President & CEO
OfficerDirector
Primary company: AbbVie Inc. (ABBV)
Gosebruch Henry O is a corporate insider (President & CEO) at AbbVie Inc. (ABBV) filing SEC Form 4 transactions. 128 transactions across 4 companies, totaling $3,568,379 in purchases and $46,355,602 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 6,662 | - | - | 6,662 | 8/19/2026 Filed: 8/19/2026 | Filing → | |
ACELYRIN, Inc. SLRN | Disposition | 155,450 | - | - | 0 | 5/21/2025 Filed: 5/23/2025 | Filing → |
ACELYRIN, Inc. SLRN | Disposition | 92,158 | - | - | 0 | 5/21/2025 Filed: 5/23/2025 | Filing → |
ACELYRIN, Inc. SLRN | Disposition | 50,000 | - | - | 0 | 5/21/2025 Filed: 5/23/2025 | Filing → |
ACELYRIN, Inc. SLRN | Award | 92,158 | - | - | 92,158 | 6/7/2024 Filed: 6/11/2024 | Filing → |
| Award | 160,000 | - | - | 160,000 | 2/14/2024 Filed: 2/16/2024 | Filing → | |
| Award | 80,000 | - | - | 462,345 | 2/14/2024 Filed: 2/16/2024 | Filing → | |
| Purchase | 15,000 | $12.62 | $189K | 15,000 | 9/19/2023 Filed: 9/19/2023 | Filing → | |
ACELYRIN, Inc. SLRN | J | 155,450 | $0.00 | $0 | 155,450 | 5/9/2023 Filed: 5/11/2023 | Filing → |
ACELYRIN, Inc. SLRN | J | 155,450 | $0.00 | $0 | 0 | 5/9/2023 Filed: 5/11/2023 | Filing → |
ACELYRIN, Inc. SLRN | Purchase | 50,000 | $18.00 | $900K | 50,000 | 5/9/2023 Filed: 5/11/2023 | Filing → |
Aptinyx Inc. APTX | Award | 40,000 | $0.00 | $0 | 40,000 | 5/26/2022 Filed: 5/31/2022 | Filing → |
AbbVie Inc. ABBV | Exercise | 83,960 | $54.86 | $4.61M | 0 | 5/16/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Sale | 83,960 | $155.00 | $13.01M | 41,623 | 5/16/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Exercise | 83,960 | $54.86 | $4.61M | 125,583 | 5/16/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Sale | 100 | $149.38 | $15K | 53,500 | 3/1/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Sale | 4,000 | $148.71 | $595K | 53,600 | 3/1/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Sale | 5,167 | $147.60 | $763K | 57,600 | 3/1/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Sale | 15,733 | $146.81 | $2.31M | 62,767 | 3/1/2022 Filed: 5/20/2022 | Filing → |
AbbVie Inc. ABBV | Exercise | 83,960 | $54.86 | $4.61M | 0 | 5/16/2022 Filed: 5/18/2022 | Filing → |
Type
Award
Shares
6,662
Price
-
Value
-
ACELYRIN, Inc.
SLRN
Type
Disposition
Shares
155,450
Price
-
Value
-
ACELYRIN, Inc.
SLRN
Type
Disposition
Shares
92,158
Price
-
Value
-
ACELYRIN, Inc.
SLRN
Type
Disposition
Shares
50,000
Price
-
Value
-
ACELYRIN, Inc.
SLRN
Type
Award
Shares
92,158
Price
-
Value
-
Type
Award
Shares
160,000
Price
-
Value
-
Type
Award
Shares
80,000
Price
-
Value
-
Type
Purchase
Shares
15,000
Price
$12.62
Value
$189K
ACELYRIN, Inc.
SLRN
Type
J
Shares
155,450
Price
$0.00
Value
$0
ACELYRIN, Inc.
SLRN
Type
J
Shares
155,450
Price
$0.00
Value
$0
ACELYRIN, Inc.
SLRN
Type
Purchase
Shares
50,000
Price
$18.00
Value
$900K
Aptinyx Inc.
APTX
Type
Award
Shares
40,000
Price
$0.00
Value
$0
AbbVie Inc.
ABBV
Type
Exercise
Shares
83,960
Price
$54.86
Value
$4.61M
AbbVie Inc.
ABBV
Type
Sale
Shares
83,960
Price
$155.00
Value
$13.01M
AbbVie Inc.
ABBV
Type
Exercise
Shares
83,960
Price
$54.86
Value
$4.61M
AbbVie Inc.
ABBV
Type
Sale
Shares
100
Price
$149.38
Value
$15K
AbbVie Inc.
ABBV
Type
Sale
Shares
4,000
Price
$148.71
Value
$595K
AbbVie Inc.
ABBV
Type
Sale
Shares
5,167
Price
$147.60
Value
$763K
AbbVie Inc.
ABBV
Type
Sale
Shares
15,733
Price
$146.81
Value
$2.31M
AbbVie Inc.
ABBV
Type
Exercise
Shares
83,960
Price
$54.86
Value
$4.61M
AI Agent
Try asking...